Conversely, in pancreatic cancer, miR-30d suppresses the proliferation and invasiveness of the cancer by targeting the SOX4/PI3K-AKT axis, with its downregulation linked to poor patient prognosis [52]. The gene discussed is AKT1; the disease is cancer.